Session date: 
Friday, January 15, 2016 - 8:00am to 9:00am
Location: 
Froedtert Hospital
9200 W Wisconsin Avenue
Dean Roe Auditorium
Milwaukee, WI 53226
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.
Program Description: 

Weekly grand rounds as a forum for clinical and basic research updates in neurology with respect to diagnosis and management of neurological disorders and advances in neuroscience.  General areas of focus will include among others the following:  neuromuscular, epilepsy, sleep, movement disorders, stroke and vascular disorders, neurodegenertive, dementia and memory disorders, headaches and cranial neuralgias, autonomic disorders, and general neurologic conditions.

Accreditation Statement
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
Designation of Credit Statement
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Hours of Participation for Allied Health Professionals
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
Target audience: 

Neurologists and Neuropsychologists as a specialty, including both generalists and sub-specialists.  Health care providers including physicians (MD's, DO's) RN, APNP, PA,  PhD, as well as students, residents, and fellows.  Also included are basic and clinical researchers and clinicians throughout neurology, neurosurgery, and neuropsychology especially during the monthly interdisciplinary grand rounds presentations.

Learning objectives: 

Gain knowledge of the state-of-art treatment options and outcomes for patients with 

                        A. Low Grade II gliomas

                        B. Grade III gliomas.

Understanding how the interaction between clinical, histological, and molecular prognostic factors

    could shape the future design of clinical trials for lower grade (II and III) gliomas.

Faculty & credentials: 


Planning Committee:
Jonathan Florczak, MD
Assistant Professor
Department of Neurology

 
David Sabsevitz, PhD, ABPP
Boart Certified in Clinical Neuropsychology
Assistant Professor of Neurology
Director of Postdoctoral Education
Medical College of Wisconsin

Presenter:

Ali Choucair, MD
Professor of Neurology
Neuro-oncology

CME Coordinator Contact Information

Name: 
Gail Balistreri
Phone number: 
+1 (414) 805-5204